Instalab
logoInstalab

Glycyphagus Domesticus (Gly d 2) IgE

Blood Test
The storage mite signal that can explain stubborn asthma or rhinitis when standard dust mite testing looks clean.
4.9 (2,940 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Glycyphagus Domesticus (Gly d 2) IgE test?

This test is most useful if any of these apply to you.

Living With Stubborn Asthma
If your asthma keeps flaring despite good treatment, this can reveal whether a storage mite is quietly driving the inflammation.
Working With Grain or Hay
Storage mites concentrate in grain, feed, and hay. This can show whether your workplace exposure has crossed into real sensitization.
Living In A Damp Home
If your home gets humid or has a basement or storage spaces, this can show whether storage mites have become an allergic trigger for you.
Already Sensitized To Dust Mites
If house dust mite testing is positive but does not fully explain your symptoms, this fills in the missing piece of your mite profile.

About Glycyphagus Domesticus (Gly d 2) IgE

If your asthma flares in damp weather, your nose runs in storage spaces or grain rooms, or your symptoms never quite match your house dust mite results, there is a different mite worth checking. Glycyphagus domesticus is a storage mite found in damp homes, farms, granaries, and warehouses, and the body can mount a targeted allergic response to one of its main proteins, called Gly d 2. This test measures the level of IgE (a type of allergy antibody) in your blood that is specifically aimed at Gly d 2.

What makes this measurement useful is that it can flag allergy to a primary sensitizer that conventional house dust mite panels often miss. In studies of homes where both house dust mites and Glycyphagus domesticus were present, only limited overlap was seen in the IgE responses to the two mite species, meaning a clear reaction to one does not automatically appear on a test for the other.

What This Test Actually Reveals

A positive result tells you that your immune system has class switched, meaning some of your B cells (a type of immune cell that makes antibodies) now produce IgE pointed specifically at Gly d 2. That is the hallmark of a memory allergic response, often called Th2 sensitization, where the body treats a harmless mite protein as a threat. The reading does not by itself diagnose allergic disease. It tells you whether your immune system is primed.

Storage mites like Glycyphagus domesticus are now recognized as primary sensitizers in their own right, not just bystanders living alongside house dust mites. In a Spanish population of mite allergic patients, Glycyphagus domesticus was present in roughly half of the homes studied, and about half of those exposed were sensitized when checked by skin and serum IgE tests. That makes Gly d 2 IgE a meaningful read on whether a real, independent sensitization is happening, especially in areas where these mites grow well.

Storage Mite Allergy and Asthma

In a published cohort of patients with moderate to severe type 2 high asthma (a form of asthma driven by allergic inflammation), a majority were sensitized to Gly d 2, and a smaller share had IgE to the full Glycyphagus domesticus extract, using a positivity threshold of at least 0.35 kUA/L. Group 2 mite allergens, the family that includes Gly d 2, were among the most frequently recognized molecules in these severe asthma patients. The implication is direct: if your asthma is hard to control and you live in a humid or storage rich environment, Gly d 2 sensitization may be quietly part of the picture.

Who Was StudiedWhat Was ComparedWhat They Found
Adults with moderate to severe type 2 high asthmaFrequency of IgE against group 2 storage mite allergensLep d 2 was the most commonly recognized, followed by Gly d 2, with Tyr p 2 also frequently positive
Mite allergic patients in southern Spain with G. domesticus in the homeCross reactivity of IgE between house dust mite and Glycyphagus domesticusRoughly half were sensitized to G. domesticus, with limited cross reactivity to the house dust mite
Farmers on GotlandCombined positive specific IgE and respiratory symptoms to four storage mites including G. domesticusStorage mite allergy in about 6% of the whole farming population, rising to over a third of those with potentially allergic respiratory symptoms

What this means for you: if you have ongoing asthma or rhinitis, especially in damp or storage rich settings, checking Gly d 2 helps explain why your inhalers, antihistamines, or environmental controls aimed at house dust mites alone may not be doing the full job.

Occupational and Damp Home Exposure

Storage mites concentrate in grain, hay, flour, stored foods, and damp building materials, which makes them an occupational hazard. In a study of 139 Danish grain elevator workers, about 16% were sensitized to storage mites including Glycyphagus domesticus when tested by blood specific IgE, and roughly 6% had respiratory storage mite allergy with symptoms. If you work with grain, animal feed, hay, or stored produce, or you live in a chronically damp home, Gly d 2 sensitization is more likely to be clinically relevant than it would be for someone in a dry urban apartment.

Why It Is Not the Same as Standard Dust Mite Testing

House dust mites (Dermatophagoides pteronyssinus and Dermatophagoides farinae) live mostly in mattresses, sofas, and carpets, while Glycyphagus domesticus belongs to a different family that thrives in higher humidity and in stored organic materials. IgE to the two groups does not consistently overlap. Studies of people naturally exposed to both species show limited cross reactivity between house dust mite and Glycyphagus domesticus, which means a clean house dust mite IgE result does not rule out storage mite sensitization. In contrast, IgE against Gly d 2 strongly travels with IgE against Lep d 2, another storage mite group 2 allergen, with the two showing extensive cross reactivity in laboratory studies.

What Your Trend Tells You

A single Gly d 2 IgE reading is best treated as a snapshot of your current sensitization, not a fixed property of your immune system. Levels can shift with recent allergen exposure, with treatment, and over years as your environment and immune profile change. In controlled nasal allergen challenges in unrelated allergies, systemic allergen specific IgE rose substantially over weeks, showing how powerfully a recent exposure can move the number even when nothing else has changed.

A practical approach is to get a baseline, retest in 3 to 6 months if you are making real changes (such as moving, remediating dampness, leaving an occupational exposure, or starting allergen immunotherapy), and then check at least annually as part of broader allergy follow up. There is no formal guideline cadence for retesting Gly d 2 IgE, so this is a reasonable clinical pattern rather than an evidence based mandate. A clear downward trend alongside symptom improvement is a stronger signal than any single value.

When Results Can Be Misleading

  • Recent allergen exposure: sustained or repeat contact with mite rich dust can temporarily push specific IgE higher. In nasal allergen challenge studies of other allergens, systemic specific IgE rose meaningfully after exposure. If you have just spent days in a granary, a damp basement, or moved house, your number may overstate your steady state level.
  • Subcutaneous omalizumab: this anti IgE drug binds free IgE and forms drug antibody complexes that can artificially raise total IgE measurements roughly 2 to 5 fold without raising true allergen specific IgE production. The result is a confused picture rather than a real biological change in your Gly d 2 response.
  • Strong sensitization to a related storage mite: because group 2 mite allergens can cross react within the storage mite family, IgE to Lep d 2 or Tyr p 2 may signal real reactivity to multiple storage mites and complicate the interpretation of any single component result.
  • Cross reactive carbohydrate determinants: some IgE binding to mite extracts comes from sugar structures shared with other species, which can produce positive signals that do not always translate into clinical symptoms when whole extract testing is used.

What To Do With An Out Of Pattern Result

Treat a positive Gly d 2 result as one piece of a larger map. Pair it with IgE to other storage mite components such as Lep d 2 and Tyr p 2 to see whether your immune system is broadly recognizing storage mites or focused on Glycyphagus. Add IgE to house dust mite components like Der p 1, Der p 2, Der f 1, and Der f 2 to know whether you are also reacting to standard dust mites, since the management of bedroom and storage exposures is different. A total IgE level helps put your specific results in context.

If the result is positive and you have ongoing respiratory or skin symptoms, a referral to an allergist (a doctor who specializes in allergic disease) is the right next step. The conversation should cover whether component guided allergen immunotherapy is appropriate (storage mite specific extracts are less widely available than house dust mite extracts), how to reduce storage mite exposure at home and at work, and whether you need a step up in asthma or rhinitis controller medication. A negative result, especially when standard dust mite IgE is also negative but symptoms persist, should push you toward other inhalant allergens, irritant exposures, or non allergic causes rather than ending the workup.

What Moves This Biomarker

Evidence-backed interventions that affect your Glycyphagus Domesticus (Gly d 2) IgE level

↓ Decrease
Dupilumab (an injectable antibody that blocks interleukin 4 and interleukin 13 signaling)
In adults with atopic dermatitis who were not receiving allergen immunotherapy, dupilumab treatment produced a substantial decrease in allergen specific IgE alongside a rise in allergen specific IgG4. The drug works by dampening the Th2 immune signals that drive allergic class switching, so the effect reflects a real change in the underlying allergic biology rather than a measurement artifact. This study measured IgE to common food and respiratory allergens rather than Gly d 2 specifically, so the same direction of change is expected for storage mite IgE but has not been directly demonstrated.
MedicationStrong Evidence
↕ Up & Down
Allergen specific immunotherapy with storage or house dust mite extract
Long term allergen specific immunotherapy can reshape the antibody response, with allergen specific IgE often rising in the first months before declining over years, while IgG4 (a blocking antibody) rises. In a randomized study of house dust mite allergic patients, immunotherapy shifted specific IgE and increased specific IgG4 over the treatment course. A randomized trial of sublingual immunotherapy combining Dermatophagoides pteronyssinus and Blomia tropicalis extracts also significantly reduced rescue medication use in allergic rhinitis. These trials measured house dust mite or tropical mite IgE rather than Gly d 2 specifically, so the same pattern is plausible for storage mite components but has not been directly confirmed for Gly d 2.
MedicationModerate Evidence

Frequently Asked Questions

Panels containing Glycyphagus Domesticus (Gly d 2) IgE

Glycyphagus Domesticus (Gly d 2) IgE is included in these pre-built panels.

References

12 studies
  1. Hage-hamsten M, Johansson S, Hoglund S, Tull P, Wiren a, Zetterstrom OClinical & Experimental Allergy1985
  2. Revsbech P, Andersen GAllergy1987
  3. Arias-irigoyen J, Lombardero M, Arteaga C, Carpizo J, Barber DThe Journal of Allergy and Clinical Immunology2007
  4. Gonzalez-perez R, Poza-guedes P, Pineda F, Castillo M, Sanchez-machin IInternational Journal of Molecular Sciences2022